Several pharmaceutical companies developed and distributed COVID-19 vaccines at unprecedented speed, an effort widely credited with saving millions of lives during the height of the pandemic. Nearly five years later, large-scale research is prompting renewed discussion—not about failure, but about complexity. A major international study examining data from roughly 99 million people has added nuance to how vaccine safety is understood over time. Behind public messaging and political debate, clinicians have continued to document rare but serious adverse events following vaccination. These have included myocarditis, certain clotting disorders, elevated blood pressure in specific contexts, severe allergic reactions, and changes in...
Continues…